Literature DB >> 7680241

Effects of immunosuppressants, FK506, deoxyspergualin, and cyclosporine A on immature human hematopoiesis.

A Hirao1, Y Kawano, Y Takaue.   

Abstract

Effects of the immunosuppressants, FK506, deoxyspergualin (DSG), and cyclosporine A (CsA) on the growth of human hematopoietic progenitor cells were tested in the presence of interleukin-3 (IL-3) with purified bone marrow and blood cells as targets in methylcellulose culture. FK506 had a significant stimulatory effect on the growth of colony-forming units/granulocyte-macrophage (CFU-GM) and burst-forming units/erythroid (BFU-E) from peripheral blood and cord blood cells but not from bone marrow cells. Neither DSG nor CsA had an effect on any type of target cell. Liquid-suspension-limiting dilution assay with IL-3 showed that FK506 directly stimulated the growth of blood progenitors in a dose-dependent manner with single-hit kinetics. Liquid-suspension preincubation of blood cells with FK506 before culture in methylcellulose induced a significant increase in the amount of IL-3-supported growth of CFU-GM and BFU-E, whereas initial preincubation with IL-3 and subsequent culture with FK506 plus IL-3 exerted its stimulatory effect only on BFU-E. These data suggest that the stimulation of hematopoietic progenitor cells by FK506 occurs at a very early stage of maturation and diminishes with further myeloid development.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7680241

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Enhancing and suppressive effects of immunosuppressants cyclosporin A, FK506, and KM2210 on the colony formation of murine bone marrow cells.

Authors:  X Zhu; M Imamura; S Hashino; J Tanaka; S Kobayashi; H R Tao; M Asaka; M Kasai; T Matsudaira; S Asano
Journal:  Ann Hematol       Date:  1995-12       Impact factor: 3.673

2.  Therapeutic effect of cyclosporine A in thrombocytopenia after myeloablative chemotherapy in acute myeloid leukaemia.

Authors:  Y Novik; L Oleksowicz; P H Wiernik
Journal:  Med Oncol       Date:  1997-03       Impact factor: 3.064

Review 3.  Immunosuppressive treatment of acquired aplastic anemia and immune-mediated bone marrow failure syndromes.

Authors:  Neal S Young
Journal:  Int J Hematol       Date:  2002-02       Impact factor: 2.490

Review 4.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

Review 5.  Drug-Induced Hematological Cytopenia in Kidney Transplantation and the Challenges It Poses for Kidney Transplant Physicians.

Authors:  Muhammad Abdul Mabood Khalil; Muhammad Ashhad Ullah Khalil; Taqi F Taufeeq Khan; Jackson Tan
Journal:  J Transplant       Date:  2018-08-01

6.  FK506 and Cyclosporin A Enhance IL-6 Production in Monocytes: A single-Cell Assay.

Authors:  K Murayama; M Sawamura; H Murakami; J Tamura; T Naruse; J Tsuchiya
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

7.  Platelet activating factor synthesis and metabolism in intestinal ischaemia-reperfusion injury.

Authors:  M J Mangino; M Murphy; A Bohrer; J Turk
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

8.  Calcium and calcineurin-NFAT signaling regulate granulocyte-monocyte progenitor cell cycle via Flt3-L.

Authors:  Jan Fric; Clarice X F Lim; Alexandra Mertes; Bernett T K Lee; Elena Viganò; Jinmiao Chen; Francesca Zolezzi; Michael Poidinger; Anis Larbi; Herbert Strobl; Teresa Zelante; Paola Ricciardi-Castagnoli
Journal:  Stem Cells       Date:  2014-12       Impact factor: 6.277

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.